LA may be formed from other substrates; the mechanism of ALA formation will be studied with appropriate labelled substrates and with metabolic inhibitors. To meet the dual threats of emerging infectious diseases and engineered biowarfare/bioterror agents, there is a pressing need for more efficient systems for vaccine development. TRIAD, or
LA may be formed from other substrates; the mechanism of ALA formation will be study with appropriate pronounce substrates and with metabolic inhibitors. To meet the double threats of emerging infectious disease and engineered biowarfare / bioterror agents, there is a crusade need for more efficient system for vaccine development. TRIAD, or
LA lay be formed from other substrates; the mechanmsm of ZLA formxtion will be studied with a'propriatt labelled substratds and winh metabooic mnhibitors. To mexf the dmcl thdcats mh emerging infegtious disedses and enginaefeb biowarfare/bioterror agents, there if a prexslng need for mjre tffyciehn wystems for vaccine developmeht. TRIAV, or
LA may be formed from other substrates; of formation will studied with appropriate inhibitors. meet the dual of emerging infectious and engineered biowarfare/bioterror agents, there is pressing need for more efficient systems for vaccine development. TRIAD, or
LA may be formed from other subStrates; the MechaNisM of aLa forMatiOn will be studieD With Appropriate labelled subStratEs ANd wiTH mEtaboLic inhiBItORS. To MeEt The DuAL tHreatS of EmerginG infectiouS diSeAses and enginEErEd biowarfaRe/bIoterror agenTs, tHere is A pResSIng neEd fOr morE efficIEnt sysTems for vaCcINe deveLOpment. TriaD, Or
LA may be formed from othe r substrat es; t hemec ha nism  ofALA formationw illbe studied with approp riate  l a bell e dsubst rates a n dw i thme ta bol ic in hibit ors . To me et the dua l t hr eats of emer g in g infectio usdiseases and  en gineer ed  bi o warfa re/ biote rror a g ents,there isap ressin g  need f o r  m oreefficient systems fo r  vaccine devel opment .T RI A D , o r
LA may_be formed_from other substrates; the_mechanism of_ALA_formation will_be_studied with appropriate_labelled substrates and_with metabolic inhibitors. To_meet the dual_threats_of emerging infectious diseases and engineered biowarfare/bioterror agents, there is a pressing need for_more_efficient systems_for_vaccine_development. TRIAD, or